Hematologic Disorders in Pregnancy
Anemia is the most common maternal problem during pregnancy. Anemia is a variation in hemoglobin concentration.
Pregnant woman will lose blood during delivery and the puerperium, and an anemic woman is at increased risk of blood transfusion and its related conditions.
During pregnancy, the blood volume increases by approximately 50% and the red blood cell mass by approximately 33%. This relatively greater increase in plasma volume results in a lower hematocrit but does not truly represent anemia.
Anemia in pregnancy most commonly results from a nutritional deficiency in either iron or folate. Pernicious anemia due to vitamin B12 deficiency almost never occurs during pregnancy. Other anemias occurring during pregnancy include anemia of chronic disease; anemia due to hemoglobinopathy; immune, or drug-induced hemolytic anemia; and aplastic anemia.
Related Conference of Hematologic Disorders in Pregnancy
Hematologic Disorders in Pregnancy Conference Speakers
Recommended Sessions
- Advanced treatment and Research in hematology
- Artificial Intelligence techniques in Hematology Oncology
- Bizarre Blood Diseases
- Blood and Blood disorders
- Blood transfusion
- Bone Marrow Transplantation
- Diagnosis, Treatment And Management Of Hematology
- Entrepreneurs Investment Meet
- Genetic Blood Disorders
- Hematologic Disorders in Pregnancy
- Hematology and Hematologists
- Hematology and Pharma industry
- Hematology Nursing
- Hematology Oncology
- Hematology Veterinary
- Hematopathology
- Pediatric Hematology
- Stem cells and Disorders
- Storage and Processing of the blood
Related Journals
Are you interested in
- Biomarkers in Hematology and Oncology - Hematology Congress 2025 (Switzerland)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2025 (Switzerland)
- Cancer Genomics & Metabolomics - Hematology Congress 2025 (Switzerland)
- Case Reports in Hematology - Hematology Congress 2025 (Switzerland)
- Clinical Haematology - Hematology Congress 2025 (Switzerland)
- Cord Blood Transplantation - Hematology Congress 2025 (Switzerland)
- Digital Imaging in Hematology - Hematology Congress 2025 (Switzerland)
- Haematology and Pharma Industry - Hematology Congress 2025 (Switzerland)
- Hematologic Cancers - Hematology Congress 2025 (Switzerland)
- Hematology and Cardio-Oncology - Hematology Congress 2025 (Switzerland)
- Hematology Nursing - Hematology Congress 2025 (Switzerland)
- Hematology: Diagnostics and Screening - Hematology Congress 2025 (Switzerland)
- Hematopoietic Malignancies - Hematology Congress 2025 (Switzerland)
- Immunohematology - Hematology Congress 2025 (Switzerland)
- Neuro-Hematology - Hematology Congress 2025 (Switzerland)
- Organ Specific Cancer - Hematology Congress 2025 (Switzerland)
- Pediatric Hematology - Hematology Congress 2025 (Switzerland)
- Stem Cell Therapy - Hematology Congress 2025 (Switzerland)
- Transfusion Medicines - Hematology Congress 2025 (Switzerland)
- Vascular Bleeding Disorders - Hematology Congress 2025 (Switzerland)